Skip to contentI
InfuSystem Holdings, Inc
I
INFUInfuSystem Holdings, Inc Q2 2024 · 10-Q
Revenue$33.70M$33.70M+6.2% vs Q2 2023 Net Income$717.00K$717.00K+64.8% vs Q2 2023 EPS Diluted$0.03$0.03+50.0% vs Q2 2023 Gross Profit$16,668,000+5.3% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
InfuSystem Holdings, Inc · CIK 1337013 · Engraved from SEC EDGAR
Operating Cash Flowderived$2,309,000−5.8% Free Cash Flowderived$1,972,000−13.3% Margins · derivedGross margin49.5%−0.4 pt vs Q2 2023
Operating margin5.5%+1.6 pt vs Q2 2023
Net margin2.1%+0.8 pt vs Q2 2023
ended Jun 30, 2024 · filed Aug 9, 2024 · 40 d after period end